SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-17-000236
Filing Date
2017-02-15
Accepted
2017-02-15 16:47:32
Documents
6
Period of Report
2017-02-15

Document Format Files

Seq Description Document Type Size
1 FORM 6-K merus6k.htm 6-K 7818
2 NEWS RELEASE DATED FEBRUARY 14, 2017 ex991.htm EX-99.1 24754
3 Q1 REPORT ex992.htm EX-99.2 827320
4 CEO CERTIFICATION ex993.htm EX-99.3 12270
5 CFO CERTIFICATION ex994.htm EX-99.4 12207
6 GRAPHIC meruslogo.jpg GRAPHIC 7757
  Complete submission text file 0001279569-17-000236.txt   896455
Mailing Address 100 WELLINGTON ST. WEST SUITE 2110 P.O. BOX 151 TORONTO A6 M5K 1H1
Business Address 100 WELLINGTON ST. WEST SUITE 2110 P.O. BOX 151 TORONTO A6 M5K 1H1 416 593-3701
Merus Labs International Inc. (Filer) CIK: 0001031516 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 000-30082 | Film No.: 17615231
SIC: 2834 Pharmaceutical Preparations